Moreover, FASN expression was decreased in the tumour tissue of FASN‐shRNA2 group, accompanied by the down‐regulation of PRRX1, cyclin D1 and c‐Myc (Figure 5B). The gene discussed is CCND1; the disease is neoplasm.